Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned favorably in the biotechnology sector due to its advanced Enhanced Delivery Oligonucleotide platform, which has shown promising preclinical results in delivering oligonucleotides effectively across various tissues. With a current stock price of approximately $4 per share, the company's potential for significant upside is highlighted by best-case scenario projections indicating possible increases of 40% to 100% if clinical data demonstrates strong efficacy and safety. Additionally, PepGen's reported 53.7% splicing correction sets a high benchmark compared to competitors, reinforcing the credibility of its therapeutic advancements and suggesting that investor interest could grow as multi-dose data is released.

Bears say

PepGen Inc. is facing significant challenges that contribute to a negative outlook on its stock. Key risks include potential unexpected safety issues related to its Enhanced Delivery Oligonucleotide platform, the efficacy of PGN-EDODM1 being lower than anticipated based on earlier clinical data, and uncertainties surrounding the regulatory approval pathways for its products. Furthermore, the company's reliance on successful market execution and its ability to secure funding raises concerns about the feasibility of its development plans and meeting projected commercial revenue, which could adversely impact investor confidence and share performance.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.